改变病情的抗风湿药物(一) 被引量：1

下载PDF

导出

摘要改变病情的药物（disease modifying antirheumatic drugs，DMARDs）又称慢作用药、细胞毒药，对延缓风湿病的关节破坏有一定作用，是目前治疗风湿病的主要药物。临床常用的制剂包括甲氨喋呤、环磷酰胺、硫唑嘌呤、来氟米特、羟氯喹、吗替麦考酚酯、环孢霉素、他克莫司、柳氮磺胺吡啶、青霉胺以及金制剂。

作者王振刚

机构地区首都医科大学附属北京同仁医院

出处《临床药物治疗杂志》 2008年第4期39-45,共7页 Clinical Medication Journal

关键词抗风湿药物病情吗替麦考酚酯柳氮磺胺吡啶 DRUGS 慢作用药细胞毒药关节破坏

分类号 R971.1 [医药卫生—药品] R563.1 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献46

1唐福林.类风湿关节炎的药物治疗[J].临床药物治疗杂志,2005,3(1):18-22. 被引量：3
2[2]di Munno O,Mazzantini M,Sinigaglia L,et al.Effect of low dose methotrexate on bone density in women with rheumatoid arthritis:results from a multicenter cross-sectional study.J Rheumatol,2004,31:1305-1309
3[3]Wessels JA,Bonwstro JK,Heijmans BT,et al.efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.Arthritis Rheum,2006,54:1087-1095
4[4]Venter JC,Adams MD,Myers EW,et al.The sequence of the human genome.Science,2001,291:1304
5[5]Urano W,Tanigachi A,Yamanaka H,et al.Polymorphisms in the metrylenetetrahydrofolate reductase gene were associated with the efficacy ang the toxicity of methotrexate used for the treatment of rheumatois arthritis,as evidenced by single locus methylenetetra-hydrofolate gene and haplotype analyses.Pharmacogenetics,2002,12:183-190
6[7]Haagsma CJ,Blom HJ,van Rial PL,et al.Influence of sulphasalazine,methotrexate and the combination of both on plasma homocsteine:concentrations in patients with rheumatoid arthritis.Ann Rheum Dis,1999,58:79-84
7[8]Weismanl MH,Furst DE,Park GS,et al.Risk genorhye in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis.Arthritis Rheum,2006,54:607-612
8宋宁,王朝宏,阎锡新.甲氨蝶呤治疗类风湿关节炎致间质性肺疾病研究进展[J].中华风湿病学杂志,2006,10(6):363-366. 被引量：6
9杨会霞,朱珠.甲氨蝶呤治疗类风湿关节炎时的合理应用要点[J].中国医院药学杂志,2007,27(8):1136-1139. 被引量：6
10陈益和,唐福林.环磷酰胺在系统性红斑狼疮治疗中的应用[J].临床药物治疗杂志,2006,4(1):34-38. 被引量：4

二级参考文献135

1顾颖莉,朱汉威.环磷酰胺心脏毒性作用的研究进展[J].上海第二医科大学学报,2004,24(9):772-774. 被引量：14
2杨岫岩,朱旬,梁柳琴,詹钟平,叶玉津.环磷酰胺治疗系统性红斑狼疮导致卵巢功能衰竭的相关因素分析[J].中华医学杂志,2005,85(14):960-962. 被引量：26
3王兴元,冯奉仪,宋三泰,王华庆,张茂宏,刘健,刘叙仪,许立功,张阳.国产重组人白介素-11衍生物治疗化疗所致血小板降低的多中心临床研究2006肿瘤防治新进展济南论坛征文通知[J].中华肿瘤杂志,2005,27(6):373-376. 被引量：35
4杨岫岩,尹培达,高翔,刘亚光.系统性红斑狼疮环磷酰胺冲击治疗的最佳间期探讨[J].中华内科杂志,1996,35(4):257-260. 被引量：14
5史群唐福磷等.每周大剂量环磷酰胺冲击治疗狼疮性肾炎的体会[J].风湿病学杂志,1996,1(2):77-79.
6Boumpas DT,Austin HA,Vaughn EM,et al.Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.Lancet,1992,340:741-745.
7Gourley MF,Austin HA,Scott D,et al.Methylprednisolone and cyclophosphamide,alone or in combination,in patients with lupus nephritis.Ann Intern Med,1996,125:549-557.
8Illei GG,Austin HA,Crane M,et al.Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.Ann Intern Med,2001,135:248-257.
9Austin HA,Klippel JH,Balow JE,et al.Therapy of lupus nephritis:controlled trial of prednisolone and cytotoxic drugs.New Engl J Med,1986,314:614-619.
10Gorman C,Bhatia A,Rahman A.This house believes that lowdose intravenous cyclophosphamide is superior to standard highdose regimens for treatment of lupus nephritis.Rheumatology,2005,44:398-401.